A self-powered biosensor detects and destroys E. coli using enzyme-driven energy, aptamer-based recognition, and silver ion ...

CAMBRIDGE, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic ...

Antimicrobial nanoparticles are designed to combat bacterial resistance through mechanisms like ROS generation, membrane ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 ...

This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase ...

Bio-Path (NASDAQ:BPTH – Get Free Report) is expected to release its earnings data before the market opens on Thursday, March 6th. Analysts expect Bio-Path to post earnings of ($0.37) per share for the ...

Trichomoniasis is one of the most common sexually transmitted infections in the world. It is caused by Trichomonas vaginalis, ...

About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.